Difference between revisions of "Pharm Meeting Minutes 2021.03.17"
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
Michael tan (talk | contribs) |
||
Line 27: | Line 27: | ||
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles | :* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles | ||
− | ** Fixes something we have forgotten when we introduced COMMENT. | + | :** Fixes something we have forgotten when we introduced COMMENT. |
− | + | :* there are 2 definitions on XDS DocumentEntryType as a parameter. | |
:* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile) | :* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile) | ||
− | ** Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition. | + | :** Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition. |
:* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) | :* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles) | ||
− | ** Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction | + | :** Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction |
:* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile) | :* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile) | ||
− | ** A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known. | + | :** A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known. |
:* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile) | :* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile) | ||
− | ** Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile. | + | :** Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile. |
− | * 3 possible solutions. | + | :** 3 possible solutions. |
:* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) | :* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles) | ||
− | ** In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent. | + | :** In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent. |
:* [https://drive.google.com/file/d/1m41hAFgwzLys6nmlibP-vg9IrbUJ5Ioi/view?usp=sharing OID Tree] | :* [https://drive.google.com/file/d/1m41hAFgwzLys6nmlibP-vg9IrbUJ5Ioi/view?usp=sharing OID Tree] | ||
Revision as of 08:12, 17 March 2021
Meeting details
Location
Minutes
Q1 13:00- 14:30 Change proposals & Medication Lists
- Participants:
- Leonidas Tzimis
- Stephane Spahni
- Jose Costa Teixeira
- Michael Tan
- Jurgen Brandstatter
- Jacqueline Surugue
Change Proposals
- Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.
Overview: CP Overview
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- Fixes something we have forgotten when we introduced COMMENT.
- there are 2 definitions on XDS DocumentEntryType as a parameter.
- CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition.
- CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
- Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction
- CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
- A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known.
- CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
- Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile.
- 3 possible solutions.
- CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
- CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
- In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent.
- OID Tree
- CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
For information only:
- CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
- CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles
Medication lists
14:30- 15:00 Break
Q2 15:00- 16:30 Vaccination Topics
Participants
Work items
- Review Doc from Chriss Carr work item
Logical Model
- WHO model
- European Model
- Belgian Model
- German Model
- The IHE Pharmacy material can be found here:
https://github.com/IHE/pharm-vaccination
- and
- the WHO FHIR material can be found in Github.
https://github.com/who-int/svc